Figures & data
![](/cms/asset/7329177e-669f-40e1-aae9-a6c06d947ac9/kbie_a_2031387_uf0001_oc.jpg)
Figure 1. Flow diagram of study design.
![Figure 1. Flow diagram of study design.](/cms/asset/2812e5f9-5c74-400d-93d7-ad32a6f6b56d/kbie_a_2031387_f0001_oc.jpg)
Table 1. Comparison of baseline information
Figure 2. Expression of CD4+CXCR5+ Tfh cells in peripheral blood mononuclear cells (a) Flow cytometry-based measurement of expression of CD4+CXCR5+ Tfh cells in peripheral blood mononuclear cell (PBMCs); (b)Proportion of CD4+CXCR5+ Tfh cells in CD4+ T cells. **P < 0.01; ***P < 0.001.
![Figure 2. Expression of CD4+CXCR5+ Tfh cells in peripheral blood mononuclear cells (a) Flow cytometry-based measurement of expression of CD4+CXCR5+ Tfh cells in peripheral blood mononuclear cell (PBMCs); (b)Proportion of CD4+CXCR5+ Tfh cells in CD4+ T cells. **P < 0.01; ***P < 0.001.](/cms/asset/7266afb6-a791-49ac-be92-c1059beb1bd2/kbie_a_2031387_f0002_oc.jpg)
Figure 3. Expression of CD4+CXCR5+CD69+ cells in the peripheral blood (a-c) Flow cytometry-based measurement of expression of CD4+CXCR5+CD69+ cells in peripheral blood mononuclear cell (PBMCs) in the OS group (a), BT group (b), and Healthy group (c); (d) Proportion of CD4+CXCR5+CD69+ cells in CD4+ T cells. ***P < 0.001.
![Figure 3. Expression of CD4+CXCR5+CD69+ cells in the peripheral blood (a-c) Flow cytometry-based measurement of expression of CD4+CXCR5+CD69+ cells in peripheral blood mononuclear cell (PBMCs) in the OS group (a), BT group (b), and Healthy group (c); (d) Proportion of CD4+CXCR5+CD69+ cells in CD4+ T cells. ***P < 0.001.](/cms/asset/3fe2beb5-eadb-4a09-892d-ad5fd0ec9825/kbie_a_2031387_f0003_oc.jpg)
Figure 4. Correlation analysis between the activity level of Tfh cells and clinicopathological characteristics of osteosarcoma. (a) Tumor location; (b) Tumor size; (c) Tumor stage; (d) Tumor differentiation; (e) Presence or absence of distant metastasis. ***P < 0.001; ns, no significant.
![Figure 4. Correlation analysis between the activity level of Tfh cells and clinicopathological characteristics of osteosarcoma. (a) Tumor location; (b) Tumor size; (c) Tumor stage; (d) Tumor differentiation; (e) Presence or absence of distant metastasis. ***P < 0.001; ns, no significant.](/cms/asset/55c8b67f-5a30-4f69-a363-54887747fd48/kbie_a_2031387_f0004_b.gif)
Figure 5. Kaplan-Meier survival curve. Overall survival of osteosarcoma patients with high versus low activation levels of Tfh cells in peripheral blood.
![Figure 5. Kaplan-Meier survival curve. Overall survival of osteosarcoma patients with high versus low activation levels of Tfh cells in peripheral blood.](/cms/asset/23170e8e-86e3-4f3d-8b43-449ffb591524/kbie_a_2031387_f0005_oc.jpg)
Table 2. Univariate and multivariate Cox analysis of overall survival in osteosarcoma patients